why choose us

First received: February 27, 2024

Clinical Trial: Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Osteoarthritis

Study Type: INTERVENTIONAL


Official Title: Autologous Alpha-2 Macroglobulin Rich Plasma (A2MRP), Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis: A Pilot Study

Brief Summary: The purpose of this study is to determine the effectiveness and safety of autologous alpha-2 macroglobulin rich plasma (A2MRP) injections in the treatment of knee osteoarthritis (OA).

Read more